These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 2949680
1. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar). Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH. Ann Intern Med; 1987 Mar; 106(3):393-5. PubMed ID: 2949680 [Abstract] [Full Text] [Related]
2. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar). Selby CD, Ladusans EJ, Smith PG. Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635 [No Abstract] [Full Text] [Related]
3. [Acute hepatitis following administration of fansidar]. Meier P, Schmid M, Stäubli M. Schweiz Med Wochenschr; 1990 Feb 17; 120(7):221-5. PubMed ID: 2309111 [Abstract] [Full Text] [Related]
4. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC. Am J Trop Med Hyg; 1986 May 17; 35(3):451-8. PubMed ID: 2939735 [Abstract] [Full Text] [Related]
5. [Fansidar-induced maculopathy and dermatitis exfoliativa]. Elsås T, Hallan H. Tidsskr Nor Laegeforen; 1987 May 20; 107(14):1231-2. PubMed ID: 2955547 [No Abstract] [Full Text] [Related]
6. Erythroderma resembling sézary syndrome after treatment with Fansidar and chloroquine. Langtry JA, Harper JI, Staughton RC, Barrington P. Br Med J (Clin Res Ed); 1986 Apr 26; 292(6528):1107-8. PubMed ID: 2938663 [No Abstract] [Full Text] [Related]
8. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1985 Jan 04; 33(51-52):713-4. PubMed ID: 3917533 [No Abstract] [Full Text] [Related]
10. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. JAMA; 1985 Jan 25; 253(4):483. PubMed ID: 3881605 [No Abstract] [Full Text] [Related]
11. Fansidar and hepatic granulomas. Lazar HP, Murphy RL, Phair JP. Ann Intern Med; 1985 May 25; 102(5):722. PubMed ID: 3985527 [No Abstract] [Full Text] [Related]
13. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar). Svanbom M, Rombo L, Gustafsson L. Br Med J (Clin Res Ed); 1984 Jun 23; 288(6434):1876. PubMed ID: 6428585 [No Abstract] [Full Text] [Related]
14. [Drug-induced hepatitis caused by Fansidar]. Gersch K, Bröker HJ, Mörl H, Waldherr R. Schweiz Med Wochenschr; 1987 Oct 03; 117(40):1544-8. PubMed ID: 3118458 [Abstract] [Full Text] [Related]
15. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)]. Buser P, Räber J. Schweiz Med Wochenschr; 1985 Aug 24; 115(34):1174-6. PubMed ID: 4048913 [Abstract] [Full Text] [Related]